ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
2020 · Clinical Gastroenterology and Hepatology · 673 citations
https://doi.org/10.1016/j.cgh.2020.04.040
W
Wanguang Zhang
Tongji Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
223
Papers
5.2K
Citations
37
h-index
96
i10-index
Wanguang Zhang is an academic researcher from Tongji Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 37, co-authored 190 publications.
ORCID: 0000-0003-3184-9907Papers by this author
worksMicroenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
2020 · Experimental Hematology and Oncology · 192 citations
https://doi.org/10.1186/s40164-020-00165-3
Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
2018 · BMC Cancer · 97 citations
https://doi.org/10.1186/s12885-018-4744-4
Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
2024 · Advanced Science · 82 citations
https://doi.org/10.1002/advs.202401399
Learning Curve in Robot-Assisted Laparoscopic Liver Resection
2018 · Journal of Gastrointestinal Surgery · 71 citations
https://doi.org/10.1007/s11605-018-3689-x
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 <sup>+</sup> T cell-mediated antitumour immunity and improves anti-PD-1 efficacy
2023 · Gut · 65 citations
https://doi.org/10.1136/gutjnl-2023-331342
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat